Παρασκευή 9 Φεβρουαρίου 2018

Targeting HSF1: a prime integrator of proteotoxic stress response in myeloma

The HSF1 transcription factor is an integrator of the cellular stress response and its expression has demonstrated poor prognosis in multiple myeloma. Novel anti-HSF1 small molecule inhibitors CCT251236 and KRIB11 demonstrate in vitro and in vivo anti-myeloma activity, representing a novel approach for targeting the heat shock response in myeloma.



from Cancer via ola Kala on Inoreader http://ift.tt/2simVhv
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου